HLA Polymorphisms And TKI-Induced Liver Injury in Patients with Cancer: A Meta-analysis

Background: Tyrosine kinase inhibitors (TKIs) are widely used for patients with cancer, although liver injury has been observed in a small proportion of these patients. The aim of this study was to investigate the mechanisms underlying TKI-induced liver injury according to HLA polymorphisms. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Qian, Zhang, Zhuo, Wu, Yingchao, Zuo, Shuai, Liu, Qianxin, Liu, Tao, Wang, Xin, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584402/
https://www.ncbi.nlm.nih.gov/pubmed/31258719
http://dx.doi.org/10.7150/jca.26727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584402/
https://www.ncbi.nlm.nih.gov/pubmed/31258719
http://dx.doi.org/10.7150/jca.26727

Ejemplares similares